Colchicine Clinical Trials

7 recruitingLast updated: June 18, 2026

There are 7 actively recruiting colchicine clinical trials across 4 countries. Studies span Phase 4, Not Applicable, Phase 1, Phase 2, Phase 3. Top locations include Shanghai, China, Chongqing, China, Dalian, China. Updated daily from ClinicalTrials.gov.


Colchicine Trials at a Glance

7 actively recruiting trials for colchicine are listed on ClinicalTrialsFinder across 6 cities in 4 countries. The largest study group is Phase 4 with 3 trials, with the heaviest enrollment activity in Shanghai, Chongqing, and Dalian. Lead sponsors running colchicine studies include Beijing Anzhen Hospital, I.M. Sechenov First Moscow State Medical University, and Ayesha Ather.

Browse colchicine trials by phase

Treatments under study

About Colchicine Clinical Trials

Looking for clinical trials for Colchicine? There are currently 6 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Colchicine trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Colchicine clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting
Phase 4

Colchicine's Effect on Inflammatory Markers

ColchicinePost-operative Atrial FibrillationInflammation in Cardiac Surgery+2 more
Ayesha Ather24 enrolled1 locationNCT07287345
Recruiting

Ilaris NIS in Korea

Systemic Juvenile Idiopathic Arthritis (sJIA)Hereditary Periodic Fever SyndromesCryopyrin-associated Periodic Syndromes (CAPS)+3 more
Novartis Pharmaceuticals25 enrolled1 locationNCT06838143
Recruiting
Phase 4

Pilot Trial of Colchicine for Graft Failure in CABG

Graft FailureCABGColchicine
Ruijin Hospital100 enrolled1 locationNCT06802926
Recruiting
Phase 4

The Effect of Colchicine on the Occurrence of Atrial Fibrillation After Cardiac Surgery

Atrial FibrillationCoronary Artery DiseaseCoronary Artery Bypass Grafting+1 more
Tomsk Cardiology Research Institute140 enrolled1 locationNCT06798714
Recruiting
Phase 1Phase 2

Colchicine in Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction

HFpEF - Heart Failure With Preserved Ejection FractionColchicine
I.M. Sechenov First Moscow State Medical University40 enrolled2 locationsNCT05637398
Recruiting
Phase 3

Efficacy and Safety of Colchicine After PCI

Coronary Heart DiseasePercutaneous Coronary InterventionColchicine
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology8,862 enrolled36 locationsNCT06472908
Recruiting
Not Applicable

Treatment of ACuTe Coronary Syndromes With Low-dose colchICine

Acute Coronary SyndromeColchicineUnstable Angina+2 more
Beijing Anzhen Hospital6,574 enrolled1 locationNCT06215989